Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Long-term Investment Intensity
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Long-term Investment Intensity of 4.0% as of September 2019. Long-term investments of CN¥2.18 Billion represent 4.0% of total assets of CN¥54.32 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600332 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 4.0%, reflecting long-term investments of CN¥2.18 Billion against total assets of CN¥54.32 Billion CNY. Explore Guangzhou Baiyunshan Pharmaceutical Hold debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2015 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Guangzhou Baiyunshan Pharmaceutical Hold stock valuation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.0% | CN¥2.07 Billion | CN¥51.48 Billion | ▼ -6.1 pp |
| 2016 | 10.1% | CN¥2.62 Billion | CN¥25.90 Billion | ▼ -5.3 pp |
| 2015 | 15.4% | CN¥2.44 Billion | CN¥15.87 Billion | — |